研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2021 年 · SiM
Statistics in Medicine,2021 年发表的 373 篇,新的在前。点标题看作者和摘要。回到 2021 年
- Two‐phase sample selection strategies for design and analysis in post‐genome‐wide association fine‐mapping studies · SiM · 2021-12-30 · 在第 1 页
- Double‐wavelet transform for multi‐subject resting state functional magnetic resonance imaging data · SiM · 2021-12-30 · 在第 1 页
- Practical recommendations on double score matching for estimating causal effects · SiM · 2021-12-26 · 在第 1 页
- An extension of the mixed‐effects growth model that considers between‐person differences in the within‐subject variance and the autocorrelation · SiM · 2021-12-26 · 在第 1 页
- Ranked set sampling in finite populations with bivariate responses: An application to an osteoporosis study · SiM · 2021-12-20 · 在第 1 页
- Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity · SiM · 2021-12-19 · 在第 1 页
- Minimum sample size calculations for external validation of a clinical prediction model with a time‐to‐event outcome · SiM · 2021-12-16 · 在第 1 页
- Complex survival trial design by the product integration method · SiM · 2021-12-15 · 在第 1 页
- Risk prediction models for discrete ordinal outcomes: Calibration and the impact of the proportional odds assumption · SiM · 2021-12-12 · 在第 2 页
- Multivariate log‐contrast regression with sub‐compositional predictors: Testing the association between preterm infants' gut microbiome and neurobehavioral outcomes · SiM · 2021-12-12 · 在第 2 页
- Determination of the number of observers needed to evaluate a subjective test and its application in two PD‐L1 studies · SiM · 2021-12-12 · 在第 2 页
- Bayesian regularization for a nonstationary Gaussian linear mixed effects model · SiM · 2021-12-12 · 在第 2 页
- A puzzle of proportions: Two popular Bayesian tests can yield dramatically different conclusions · SiM · 2021-12-12 · 在第 2 页
- Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response · SiM · 2021-12-09 · 在第 2 页
- Estimation and inference for multikink expectile regression with longitudinal data · SiM · 2021-12-09 · 在第 2 页
- Bayesian multivariate network meta‐analysis model for the difference in restricted mean survival times · SiM · 2021-12-09 · 在第 2 页
- Methods to assess evidence consistency in dose‐response model based network meta‐analysis · SiM · 2021-12-05 · 在第 2 页
- Marginal indirect standardization using latent clustering on multiple hospitals · SiM · 2021-12-05 · 在第 2 页
- Conditional Gaussian graphical model for estimating personalized disease symptom networks · SiM · 2021-12-05 · 在第 2 页
- Extending Hui‐Walter framework to correlated outcomes with application to diagnosis tests of an eye disease among premature infants · SiM · 2021-12-03 · 在第 3 页
- Bayesian transformation models with partly interval‐censored data · SiM · 2021-11-30 · 在第 3 页
- Avoiding bias in self‐controlled case series studies of coronavirus disease 2019 · SiM · 2021-11-30 · 在第 3 页
- BIPSE: A biomarker‐based phase I/II design for immunotherapy trials with progression‐free survival endpoint · SiM · 2021-11-25 · 在第 4 页
- Feature selection and classification over the network with missing node observations · SiM · 2021-11-23 · 在第 4 页
- Event‐specific win ratios for inference with terminal and non‐terminal events · SiM · 2021-11-23 · 在第 4 页
- A semiparametric Gumbel regression model for analyzing longitudinal data with non‐normal tails · SiM · 2021-11-23 · 在第 4 页
- A conditional autoregressive model for genetic association analysis accounting for genetic heterogeneity · SiM · 2021-11-22 · 在第 4 页
- Using fractional polynomials and restricted cubic splines to model non‐proportional hazards or time‐varying covariate effects in the Cox regression model · SiM · 2021-11-21 · 在第 4 页
- A semiparametric risk score for physical activity · SiM · 2021-11-21 · 在第 4 页
- Robust and flexible inference for the covariate‐specific receiver operating characteristic curve · SiM · 2021-11-20 · 在第 4 页
- Improving main analysis by borrowing information from auxiliary data · SiM · 2021-11-18 · 在第 4 页
- A penalization approach to random‐effects meta‐analysis · SiM · 2021-11-18 · 在第 4 页
- Risk controlled decision trees and random forests for precision Medicine · SiM · 2021-11-16 · 在第 5 页
- Multiple imputation confidence intervals for the mean of the discrete distributions for incomplete data · SiM · 2021-11-16 · 在第 5 页
- Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies · SiM · 2021-11-16 · 在第 5 页
- A doubly robust method to handle missing multilevel outcome data with application to the China Health and Nutrition Survey · SiM · 2021-11-16 · 在第 5 页
- M&M: A maximum duration design with the Maxcombo test for a group sequential trial of an immunotherapy with a random delayed treatment effect · SiM · 2021-11-15 · 在第 5 页
- Cancer immunotherapy trial design with random delayed treatment effect and cure rate · SiM · 2021-11-15 · 在第 5 页
- RCRdiff: A fully integrated Bayesian method for differential expression analysis using raw NanoString nCounter data · SiM · 2021-11-12 · 在第 5 页
- A group‐sequential randomized trial design utilizing supplemental trial data · SiM · 2021-11-09 · 在第 5 页
- Conditional information and inference in response‐adaptive allocation designs · SiM · 2021-11-08 · 在第 5 页
- Optimal adaptive allocation using deep reinforcement learning in a dose‐response study · SiM · 2021-11-07 · 在第 5 页
- Estimation of standard deviations and inverse‐variance weights from an observed range · SiM · 2021-11-07 · 在第 5 页
- Bayesian spatial models for voxel‐wise prostate cancer classification using multi‐parametric magnetic resonance imaging data · SiM · 2021-11-07 · 在第 5 页
- A Bayesian phase I/II platform design for co‐developing drug combination therapies for multiple indications · SiM · 2021-11-03 · 在第 5 页
- Weighted generalized estimating equations and unified estimation for longitudinal data with nonmonotone missing data patterns · SiM · 2021-11-02 · 在第 6 页
- Multiple imputation procedures for estimating causal effects with multiple treatments with application to the comparison of healthcare providers · SiM · 2021-11-02 · 在第 6 页
- A joint model for multivariate longitudinal and survival data to discover the conversion to Alzheimer's disease · SiM · 2021-11-02 · 在第 6 页
- A causal data fusion method for the general exposure and outcome · SiM · 2021-11-02 · 在第 6 页
- Penalized Poisson model for network meta‐analysis of individual patient time‐to‐event data · SiM · 2021-10-28 · 在第 6 页
- Introduction to computational causal inference using reproducible Stata, R, and Python code: A tutorial · SiM · 2021-10-28 · 在第 6 页
- Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances · SiM · 2021-10-27 · 在第 6 页
- Bayesian model‐averaged meta‐analysis in medicine · SiM · 2021-10-27 · 在第 6 页
- Optimal diagnostic test allocation strategy during the COVID‐19 pandemic and beyond · SiM · 2021-10-25 · 在第 6 页
- Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiers · SiM · 2021-10-25 · 在第 6 页
- Response‐adaptive treatment allocation for clinical studies with recurrent event and terminal event data · SiM · 2021-10-24 · 在第 6 页
- Weighted least‐squares regression with competing risks data · SiM · 2021-10-23 · 在第 6 页
- New methods for multiple testing in permutation inference for the general linear model · SiM · 2021-10-23 · 在第 6 页
- Set‐regression with applications to subgroup analysis · SiM · 2021-10-20 · 在第 6 页
- Propensity score methods for merging observational and experimental datasets · SiM · 2021-10-20 · 在第 6 页
- MOVER confidence intervals for a difference or ratio effect parameter under stratified sampling · SiM · 2021-10-20 · 在第 6 页
- Identification of geographic clusters for temporal heterogeneity with application to dengue surveillance · SiM · 2021-10-20 · 在第 6 页
- Bayesian consensus clustering for multivariate longitudinal data · SiM · 2021-10-20 · 在第 6 页
- Robust group variable screening based on maximum Lq‐likelihood estimation · SiM · 2021-10-17 · 在第 6 页
- Censoring‐robust time‐dependent receiver operating characteristic curve estimators · SiM · 2021-10-17 · 在第 6 页
- Bayesian semiparametric joint modeling of longitudinal explanatory variables of mixed types and a binary outcome · SiM · 2021-10-17 · 在第 6 页
- A simulation study of disaggregation regression for spatial disease mapping · SiM · 2021-10-17 · 在第 6 页
- Ratio estimators of intervention effects on event rates in cluster randomized trials · SiM · 2021-10-15 · 在第 7 页
- Measurement errors in control risk regression: A comparison of correction techniques · SiM · 2021-10-15 · 在第 7 页
- Bayesian inference and dynamic prediction of multivariate joint model with functional data: An application to Alzheimer's disease · SiM · 2021-10-14 · 在第 7 页
- Adaptively stacking ensembles for influenza forecasting · SiM · 2021-10-14 · 在第 7 页
- Joint inference about the AUC and Youden index for paired biomarkers · SiM · 2021-10-12 · 在第 7 页
- Semiparametric regression analysis of clustered interval‐censored failure time data with a cured subgroup · SiM · 2021-10-11 · 在第 7 页
- Estimating the optimal timing of surgery by imputing potential outcomes · SiM · 2021-10-11 · 在第 7 页
- Comparing the sensitivities of two screening tests in nonblinded randomized paired screen‐positive trials with differential screening uptake · SiM · 2021-10-10 · 在第 7 页
- Robust approach for variable selection with high dimensional longitudinal data analysis · SiM · 2021-10-07 · 在第 7 页
- A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials · SiM · 2021-09-29 · 在第 8 页
- On a new piecewise regression model with cure rate: Diagnostics and application to medical data · SiM · 2021-09-28 · 在第 8 页
- Combining multiple imputation with raking of weights: An efficient and robust approach in the setting of nearly true models · SiM · 2021-09-28 · 在第 8 页
- Household transmission of influenza A and B within a prospective cohort during the 2013‐2014 and 2014‐2015 seasons · SiM · 2021-09-27 · 在第 8 页
- Joint modeling of multivariate nonparametric longitudinal data and survival data: A local smoothing approach · SiM · 2021-09-25 · 在第 8 页
- Leveraging real‐world evidence for determining performance goals for medical device studies · SiM · 2021-09-24 · 在第 8 页
- Power calculation for analyses of cross‐sectional stepped‐wedge cluster randomized trials with binary outcomes via generalized estimating equations · SiM · 2021-09-23 · 在第 9 页
- Robust method for optimal treatment decision making based on survival data · SiM · 2021-09-22 · 在第 9 页
- Partially linear single‐index generalized mean residual life models · SiM · 2021-09-22 · 在第 9 页
- Use of the likelihood reduction factor in a path analysis framework to quantify surrogacy in clinical trials · SiM · 2021-09-21 · 在第 9 页
- Penalized variable selection for cause‐specific hazard frailty models with clustered competing‐risks data · SiM · 2021-09-20 · 在第 9 页
- Interaction screening for high‐dimensional heterogeneous data via robust hybrid metrics · SiM · 2021-09-20 · 在第 9 页
- Identification and inference for subgroups with differential treatment efficacy from randomized controlled trials with survival outcomes through multiple testing · SiM · 2021-09-20 · 在第 9 页
- Gene‐gene interaction analysis incorporating network information via a structured Bayesian approach · SiM · 2021-09-20 · 在第 9 页
- Bayesian inference of dependent kappa for binary ratings · SiM · 2021-09-20 · 在第 9 页
- A Bayesian approach for event predictions in clinical trials with time‐to‐event outcomes · SiM · 2021-09-20 · 在第 9 页
- Matching on poset‐based average rank for multiple treatments to compare many unbalanced groups · SiM · 2021-09-16 · 在第 9 页
- Probability bound analysis: A novel approach for quantifying parameter uncertainty in decision‐analytic modeling and cost‐effectiveness analysis · SiM · 2021-09-15 · 在第 9 页
- Mixture proportional hazards cure model with latent variables · SiM · 2021-09-15 · 在第 9 页
- Inverse probability weighting and doubly robust standardization in the relative survival framework · SiM · 2021-09-15 · 在第 9 页
- Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm · SiM · 2021-09-15 · 在第 9 页
- Spatial modeling of epidermal nerve fiber patterns · SiM · 2021-09-14 · 在第 9 页
- Joint analysis of longitudinal measurements and spatially clustered competing risksHIV/AIDSdata · SiM · 2021-09-13 · 在第 10 页
- Informing power and sample size calculations when using inverse probability of treatment weighting using the propensity score · SiM · 2021-09-12 · 在第 10 页
- Incorporating survival data into case‐control studies with incident and prevalent cases · SiM · 2021-09-12 · 在第 10 页
- Frailty modeling under a selective sampling protocol: an application to type 1 diabetes related autoantibodies · SiM · 2021-09-08 · 在第 10 页
- Bayesian workflow for disease transmission modeling in Stan · SiM · 2021-09-08 · 在第 10 页
- A simplified stochastic EM algorithm for cure rate model with negative binomial competing risks: An application to breast cancer data · SiM · 2021-09-08 · 在第 10 页
- Step‐adjusted tree‐based reinforcement learning for evaluating nested dynamic treatment regimes using test‐and‐treat observational data · SiM · 2021-09-07 · 在第 10 页
- Predictive generalized varying‐coefficient longitudinal model · SiM · 2021-09-07 · 在第 10 页
- Incorporating external data into the analysis of clinical trials via Bayesian additive regression trees · SiM · 2021-09-07 · 在第 10 页
- Geographically weighted generalized Farrington algorithm for rapid outbreak detection over short data accumulation periods · SiM · 2021-09-07 · 在第 10 页
- Best practices in statistical computing · SiM · 2021-09-06 · 在第 10 页
- A bias correction method in meta‐analysis of randomized clinical trials with no adjustments for zero‐inflated outcomes · SiM · 2021-09-03 · 在第 10 页
- Quantifying the feasibility of shortening clinical trial duration using surrogate markers · SiM · 2021-09-02 · 在第 10 页
- Kernel density estimation in mixture models with known mixture proportions · SiM · 2021-09-02 · 在第 10 页
- A simulation‐extrapolation approach for regression analysis of misclassified current status data with the additive hazards model · SiM · 2021-09-02 · 在第 10 页
- Penalized regression calibration: A method for the prediction of survival outcomes using complex longitudinal and high‐dimensional data · SiM · 2021-08-31 · 在第 11 页
- Accounting for not‐at‐random missingness through imputation stacking · SiM · 2021-08-29 · 在第 11 页
- Flexible co‐data learning for high‐dimensional prediction · SiM · 2021-08-26 · 在第 11 页
- Sample size re‐estimation in clinical trials · SiM · 2021-08-25 · 在第 11 页
- A Bayesian approach for estimating typhoid fever incidence from large‐scale facility‐based passive surveillance data · SiM · 2021-08-24 · 在第 11 页
- The statistical properties of RCTs and a proposal for shrinkage · SiM · 2021-08-23 · 在第 11 页
- Multiple imputation of semi‐continuous exposure variables that are categorized for analysis · SiM · 2021-08-23 · 在第 11 页
- Bias correction for estimates from linear excess relative risk models in small case‐control studies · SiM · 2021-08-21 · 在第 11 页
- A Bayesian nonparametric approach to dynamic item‐response modeling: An application to the GUSTO cohort study · SiM · 2021-08-19 · 在第 11 页
- Bayesian hierarchical models for high‐dimensional mediation analysis with coordinated selection of correlated mediators · SiM · 2021-08-17 · 在第 11 页
- A tutorial on individualized treatment effect prediction from randomized trials with a binary endpoint · SiM · 2021-08-16 · 在第 11 页
- Multiple imputation for handling missing outcome data in randomized trials involving a mixture of independent and paired data · SiM · 2021-08-15 · 在第 11 页
- Modeling conditional reference regions: Application to glycemic markers · SiM · 2021-08-15 · 在第 11 页
- When should matching be used in the design of cluster randomized trials? · SiM · 2021-08-14 · 在第 11 页
- Composite likelihood inference for ordinal periodontal data with replicated spatial patterns · SiM · 2021-08-11 · 在第 12 页
- Estimating adjusted risk differences by multiply‐imputing missing control binary potential outcomes following propensity score‐matching · SiM · 2021-08-10 · 在第 12 页
- A multivariate statistical approach to predict COVID‐19 count data with epidemiological interpretation and uncertainty quantification · SiM · 2021-08-10 · 在第 12 页
- Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomization · SiM · 2021-08-02 · 在第 12 页
- Restricted sub‐tree learning to estimate an optimal dynamic treatment regime using observational data · SiM · 2021-08-02 · 在第 12 页
- Pleiotropy robust methods for multivariable Mendelian randomization · SiM · 2021-08-02 · 在第 12 页
- Estimating the marginal effect of a continuous exposure on an ordinal outcome using data subject to covariate‐driven treatment and visit processes · SiM · 2021-08-02 · 在第 12 页
- Using knockoffs for controlled predictive biomarker identification · SiM · 2021-07-30 · 在第 13 页
- Effective disease surveillance by using covariate information · SiM · 2021-07-30 · 在第 13 页
- A permutation‐based approach for heterogeneous meta‐analyses of rare events · SiM · 2021-07-30 · 在第 13 页
- A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials · SiM · 2021-07-30 · 在第 13 页
- Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms · SiM · 2021-07-27 · 在第 13 页
- Bayes estimate of primary threshold in clusterwise functional magnetic resonance imaging inferences · SiM · 2021-07-26 · 在第 13 页
- Unit information prior for adaptive information borrowing from multiple historical datasets · SiM · 2021-07-24 · 在第 13 页
- Penalized regression for left‐truncated and right‐censored survival data · SiM · 2021-07-24 · 在第 13 页
- Confidence intervals of prediction accuracy measures for multivariable prediction models based on the bootstrap‐based optimism correction methods · SiM · 2021-07-24 · 在第 13 页
- Connecting Instrumental Variable methods for causal inference to the Estimand Framework · SiM · 2021-07-21 · 在第 14 页
- A forward search algorithm for detecting extreme study effects in network meta‐analysis · SiM · 2021-07-21 · 在第 14 页
- Weighted expectile regression for right‐censored data · SiM · 2021-07-17 · 在第 14 页
- Authors' reply to “Comments on Identifying inconsistency in network meta‐analysis: Is the net heat plot a reliable method?” · SiM · 2021-07-16 · 在第 14 页
- Causal mediation analysis with latent subgroups · SiM · 2021-07-15 · 在第 14 页
- Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens · SiM · 2021-07-14 · 在第 14 页
- A graph convolutional neural network for gene expression data analysis with multiple gene networks · SiM · 2021-07-14 · 在第 14 页
- k‐Resolution sequential randomization procedure to improve covariates balance in a randomized experiment · SiM · 2021-07-13 · 在第 14 页
- Window mean survival time · SiM · 2021-07-13 · 在第 14 页
- Fitting marginal models in small samples: A simulation study of marginalized multilevel models and generalized estimating equations · SiM · 2021-07-12 · 在第 14 页
- Continuous positive airway pressure adherence trajectories in sleep apnea: Clustering with summed discrete Fréchet and dynamic time warping dissimilarities · SiM · 2021-07-12 · 在第 14 页
- Sample size considerations for matched‐pair cluster randomization design with incomplete observations of binary outcomes · SiM · 2021-07-09 · 在第 14 页
- Precision Bayesian phase I‐II dose‐finding based on utilities tailored to prognostic subgroups · SiM · 2021-07-09 · 在第 14 页
- Lasso estimation of hierarchical interactions for analyzing heterogeneity of treatment effect · SiM · 2021-07-08 · 在第 14 页
- Group sequential Holm and Hochberg procedures · SiM · 2021-07-08 · 在第 14 页
- Adjusted logistic propensity weighting methods for population inference using nonprobabilityvolunteer‐basedepidemiologic cohorts · SiM · 2021-07-05 · 在第 15 页
- On the normalized power prior · SiM · 2021-07-04 · 在第 15 页
- A comparison of confidence distribution approaches for rare event meta‐analysis · SiM · 2021-07-04 · 在第 15 页
- Using population crossover trials to improve the decision process regarding treatment individualization in N‐of‐1 trials · SiM · 2021-07-02 · 在第 15 页
- Seamless phase I/II design for novel anticancer agents with competing disease progression · SiM · 2021-07-02 · 在第 15 页
- Ridge‐penalized adaptive Mantel test and its application in imaging genetics · SiM · 2021-07-02 · 在第 15 页
- Summary concordance index for meta‐analysis of prognosis studies with a survival outcome · SiM · 2021-06-30 · 在第 15 页
- Estimating optimal dynamic treatment strategies under resource constraints using dynamic marginal structural models · SiM · 2021-06-29 · 在第 15 页
- Assessing conditional causal effect via characteristic score · SiM · 2021-06-28 · 在第 15 页
- Prospective individual patient data meta‐analysis: Evaluating convalescent plasma for COVID‐19 · SiM · 2021-06-23 · 在第 15 页
- Principal component analysis of hybrid functional and vector data · SiM · 2021-06-23 · 在第 15 页
- Estimation of diagnostic test accuracy: A “Rule of Three” for data with repeated observations but without a gold standard · SiM · 2021-06-23 · 在第 15 页
- Variable selection for censored data using Modified Correlation Adjusted coRrelation (MCAR) scores · SiM · 2021-06-22 · 在第 15 页
- Subgroup discovery in non‐inferiority trials · SiM · 2021-06-22 · 在第 15 页
- On the time‐varying predictive performance of longitudinal biomarkers: Measure and estimation · SiM · 2021-06-22 · 在第 15 页
- Borrowing from supplemental sources to estimate causal effects from a primary data source · SiM · 2021-06-22 · 在第 15 页
- An approximate quasi‐likelihood approach for error‐prone failure time outcomes and exposures · SiM · 2021-06-22 · 在第 15 页
- Nonlinear mixed‐effects modeling of longitudinal count data: Bayesian inference about median counts based on the marginal zero‐inflated discrete Weibull distribution · SiM · 2021-06-21 · 在第 15 页
- Bayesian variable selection with a pleiotropic loss function in Mendelian randomization · SiM · 2021-06-21 · 在第 16 页
- Graphical models for mean and covariance of multivariate longitudinal data · SiM · 2021-06-17 · 在第 16 页
- Synthesizing external aggregated information in the penalized Cox regression under population heterogeneity · SiM · 2021-06-16 · 在第 16 页
- Some new confidence intervals for Kaplan‐Meier based estimators from one and two sample survival data · SiM · 2021-06-15 · 在第 16 页
- Bayesian variable selection for understanding mixtures in environmental exposures · SiM · 2021-06-15 · 在第 16 页
- The reciprocal Bayesian LASSO · SiM · 2021-06-14 · 在第 16 页
- Propensity‐score‐based meta‐analytic predictive prior for incorporating real‐world and historical data · SiM · 2021-06-14 · 在第 16 页
- Learning and confirming a class of treatment responders in clinical trials · SiM · 2021-06-14 · 在第 16 页
- Analysis of covariance under variance heteroscedasticity in general factorial designs · SiM · 2021-06-14 · 在第 16 页
- A hypothesis test of feasibility for external pilot trials assessing recruitment, follow‐up, and adherence rates · SiM · 2021-06-14 · 在第 16 页
- A copula‐based approach for dynamic prediction of survival with a binary time‐dependent covariate · SiM · 2021-06-14 · 在第 16 页
- Exact sequential test for clinical trials and post‐market drug and vaccine safety surveillance with Poisson and binary data · SiM · 2021-06-13 · 在第 16 页
- Statistical insights for crude‐rate‐based operational measures of misdiagnosis‐related harms · SiM · 2021-06-11 · 在第 16 页
- A tractable Bayesian joint model for longitudinal and survival data · SiM · 2021-06-11 · 在第 16 页
- The mechanistic analysis of founder virus data in challenge models · SiM · 2021-06-10 · 在第 16 页
- Survival mediation analysis with the death‐truncated mediator: The completeness of the survival mediation parameter · SiM · 2021-06-10 · 在第 16 页
- Integrated multiple mediation analysis: A robustness‐specificity trade‐off in causal structure · SiM · 2021-06-10 · 在第 16 页
- Inference in functional mixed regression models with applications to Positron Emission Tomography imaging data · SiM · 2021-06-10 · 在第 16 页
- Estimating heterogeneous survival treatment effect in observational data using machine learning · SiM · 2021-06-10 · 在第 16 页
- A practical response adaptive block randomization (RABR) design with analytic type I error protection · SiM · 2021-06-10 · 在第 16 页
- Sample size adaptations and evaluation of pediatric study interpretability · SiM · 2021-06-08 · 在第 16 页
- A comparison of multiple imputation strategies for handling missing data in multi‐item scales: Guidance for longitudinal studies · SiM · 2021-06-08 · 在第 17 页
- A Bayesian multiple imputation approach to bivariate functional data with missing components · SiM · 2021-06-08 · 在第 17 页
- A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rules · SiM · 2021-06-07 · 在第 17 页
- Analyzing categorical time series in the presence of missing observations · SiM · 2021-06-04 · 在第 17 页
- Estimation and construction of confidence intervals for biomarker cutoff‐points under the shortest Euclidean distance from the ROC surface to the perfection corner · SiM · 2021-06-03 · 在第 17 页
- Optimal allocation in stratified cluster‐based outcome‐dependent sampling designs · SiM · 2021-06-02 · 在第 17 页
- Bayesian sensitivity analyses for longitudinal data with dropouts that are potentially missing not at random: A high dimensional pattern‐mixture model · SiM · 2021-06-02 · 在第 17 页
- Joint modeling of longitudinal data with informative cluster size adjusted for zero‐inflation and a dependent terminal event · SiM · 2021-05-31 · 在第 18 页
- A ROC‐based test for evaluating the group difference with an application to neonatal audiology screening · SiM · 2021-05-29 · 在第 18 页
- Prediction‐driven pooled testing methods: Application to HIV treatment monitoring in Rakai, Uganda · SiM · 2021-05-28 · 在第 18 页
- Bayesian phase II clinical trial design with noncompliance · SiM · 2021-05-28 · 在第 18 页
- A two‐stage prediction model for heterogeneous effects of treatments · SiM · 2021-05-27 · 在第 18 页
- Semiparametric regression analysis of partly interval‐censored failure time data with application to an AIDS clinical trial · SiM · 2021-05-26 · 在第 18 页
- How vague is vague? How informative is informative? Reference analysis for Bayesian meta‐analysis · SiM · 2021-05-26 · 在第 18 页
- Robust estimation and variable selection for the accelerated failure time model · SiM · 2021-05-24 · 在第 18 页
- Minimum sample size for external validation of a clinical prediction model with a binary outcome · SiM · 2021-05-24 · 在第 18 页
- Category encoding method to select feature genes for the classification of bulk and single‐cell RNA‐seq data · SiM · 2021-05-24 · 在第 18 页
- Randomization‐based inference for a marginal treatment effect in stepped wedge cluster randomized trials · SiM · 2021-05-21 · 在第 18 页
- Transporting experimental results with entropy balancing · SiM · 2021-05-20 · 在第 18 页
- Efficient study design to estimate population means with multiple measurement instruments · SiM · 2021-05-20 · 在第 18 页
- Backward joint model and dynamic prediction of survival with multivariate longitudinal data · SiM · 2021-05-20 · 在第 18 页
- Simulating the dynamics of atherosclerosis to the incidence of myocardial infarction, applied to the KORA population · SiM · 2021-05-19 · 在第 18 页
- Dynamic latent variable models for the analysis of cognitive abilities in the elderly population · SiM · 2021-05-18 · 在第 18 页
- On the robustness of latent class models for diagnostic testing with no gold standard · SiM · 2021-05-14 · 在第 18 页
- Penalized estimation of the Gaussian graphical model from data with replicates · SiM · 2021-05-13 · 在第 18 页
- Propensity score weighting for causal subgroup analysis · SiM · 2021-05-12 · 在第 18 页
- Principled selection of baseline covariates to account for censoring in randomized trials with a survival endpoint · SiM · 2021-05-12 · 在第 18 页
- Monitoring COVID‐19 contagion growth · SiM · 2021-05-11 · 在第 19 页
- Enhanced empirical likelihood estimation of incubation period of COVID‐19 by integrating published information · SiM · 2021-05-11 · 在第 19 页
- The impact of adjusting for pure predictors of exposure, mediator, and outcome on the variance of natural direct and indirect effect estimators · SiM · 2021-05-10 · 在第 19 页
- Vaccine adverse event enrichment tests · SiM · 2021-05-09 · 在第 19 页
- Measuring rater bias in diagnostic tests with ordinal ratings · SiM · 2021-05-09 · 在第 19 页
- Fine‐Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1 · SiM · 2021-05-09 · 在第 19 页
- Thoughts on “AIDSandCOVID‐19: A Tale of Two Pandemics and the Role of Statisticians” by Susan S. Ellenberg and Jeffrey S. Morris · SiM · 2021-05-08 · 在第 19 页
- Target estimands for efficient decision making: Response to comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study” · SiM · 2021-05-08 · 在第 19 页
- Statistical successes and failures during the COVID‐19 pandemic: Comments on Ellenberg and Morris · SiM · 2021-05-08 · 在第 19 页
- Semiparametric analysis of zero‐inflated recurrent events with a terminal event · SiM · 2021-05-08 · 在第 19 页
- On the role of statisticians and modelers in responding to AIDS and COVID‐19 · SiM · 2021-05-08 · 在第 19 页
- Conflating marginal and conditional treatment effects: Comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study” · SiM · 2021-05-08 · 在第 19 页
- Commentary on the role of statisticians in pandemics · SiM · 2021-05-08 · 在第 19 页
- AIDS and COVID: A tale of two pandemics and the role of statisticians · SiM · 2021-05-08 · 在第 19 页
- Contamination: How much can an individually randomized trial tolerate? · SiM · 2021-05-07 · 在第 19 页
- Bayesian adaptive design for clinical trials in Duchenne muscular dystrophy · SiM · 2021-05-07 · 在第 19 页
- A new regression model for overdispersed binomial data accounting for outliers and an excess of zeros · SiM · 2021-05-07 · 在第 19 页
- Nowcasting COVID‐19 incidence indicators during the Italian first outbreak · SiM · 2021-05-06 · 在第 19 页
- Novel application of a discrete time‐to‐event model for randomized oral immunotherapy clinical trials with repeat food challenges · SiM · 2021-05-06 · 在第 19 页
- Developing more generalizable prediction models from pooled studies and large clustered data sets · SiM · 2021-05-05 · 在第 19 页
- A multistate survival model of the natural history of cancer using data from screened and unscreened population · SiM · 2021-05-05 · 在第 19 页
- Using generalized linear models to implement g‐estimation for survival data with time‐varying confounding · SiM · 2021-05-04 · 在第 19 页
- Degrees of necessity and of sufficiency: Further results and extensions, with an application to covid‐19 mortality in Austria · SiM · 2021-05-04 · 在第 19 页
- Measuring association among censored antibody titer data · SiM · 2021-05-03 · 在第 20 页
- Design of phase III trials with long‐term survival outcomes based on short‐term binary results · SiM · 2021-05-03 · 在第 20 页
- Confidence interval estimation for treatment effects in cluster randomization trials based on ranks · SiM · 2021-05-03 · 在第 20 页
- Replicability of studies following a dual‐criterion design · SiM · 2021-04-29 · 在第 20 页
- Promotion time cure rate model with a neural network estimated nonparametric component · SiM · 2021-04-29 · 在第 20 页
- Biomarker evaluation under imperfect nested case‐control design · SiM · 2021-04-29 · 在第 20 页
- Assessment of heterogeneous treatment effect estimation accuracy via matching · SiM · 2021-04-29 · 在第 20 页
- Assessing vaccine durability in randomized trials following placebo crossover · SiM · 2021-04-29 · 在第 20 页
- Is group testing ready for prime‐time in disease identification? · SiM · 2021-04-28 · 在第 20 页
- Score tests for scale effects, with application to genomic analysis · SiM · 2021-04-27 · 在第 20 页
- Confidence interval estimation for sensitivity and difference between two sensitivities at a given specificity under tree ordering · SiM · 2021-04-27 · 在第 20 页
- Biomarker‐guided heterogeneity analysis of genetic regulations via multivariate sparse fusion · SiM · 2021-04-27 · 在第 20 页
- Bayesian semiparametric mixed effects models for meta‐analysis of the literature data : An application to cadmium toxicity studies · SiM · 2021-04-27 · 在第 20 页
- Multilevel modeling of spatially nested functional data: Spatiotemporal patterns of hospitalization rates in the US dialysis population · SiM · 2021-04-26 · 在第 20 页
- Causal mediation analysis with sure outcomes of random events model · SiM · 2021-04-26 · 在第 20 页
- Sequential knockoffs for continuous and categorical predictors: With application to a large psoriatic arthritis clinical trial pool · SiM · 2021-04-25 · 在第 20 页
- Regression analysis of arbitrarily censored survival data under the proportional odds model · SiM · 2021-04-21 · 在第 21 页
- Semiparametric recurrent event vs time‐to‐first‐event analyses in randomized trials: Estimands and model misspecification · SiM · 2021-04-20 · 在第 21 页
- Incorporating partial adherence into the principal stratification analysis framework · SiM · 2021-04-20 · 在第 21 页
- Selection of within‐run quality control rules for laboratory biomarkers · SiM · 2021-04-19 · 在第 21 页
- Computing the polytomous discrimination index · SiM · 2021-04-18 · 在第 21 页
- Win odds: An adaptation of the win ratio to include ties · SiM · 2021-04-16 · 在第 21 页
- Simultaneous modeling of Alzheimer's disease progression via multiple cognitive scales · SiM · 2021-04-14 · 在第 21 页
- New partition based measures for data compatibility and information gain · SiM · 2021-04-14 · 在第 21 页
- Variational Bayesian partially linear mean shift models for high‐dimensional Alzheimer's disease neuroimaging data · SiM · 2021-04-13 · 在第 21 页
- Cost‐efficient clinical studies with continuous time survival outcomes · SiM · 2021-04-13 · 在第 21 页
- Bayesian semiparametricmeta‐analytic‐predictiveprior for historical control borrowing in clinical trials · SiM · 2021-04-13 · 在第 21 页
- Hidden mover‐stayer model for disease progression accounting for misclassified and partially observed diagnostic tests: Application to the natural history of human papillomavirus and cervical precancer · SiM · 2021-04-12 · 在第 21 页
- Early completion of phase I cancer clinical trials with Bayesian optimal interval design · SiM · 2021-04-12 · 在第 22 页
- Bayesian network meta‐regression hierarchical models using heavy‐tailed multivariate random effects with covariate‐dependent variances · SiM · 2021-04-12 · 在第 22 页
- Sparse group regularization for semi‐continuous transportation data · SiM · 2021-04-11 · 在第 22 页
- Robust covariance estimation for high‐dimensional compositional data with application to microbial communities analysis · SiM · 2021-04-11 · 在第 22 页
- Multithreshold change plane model: Estimation theory and applications in subgroup identification · SiM · 2021-04-11 · 在第 22 页
- Evaluation of predictive model performance of an existing model in the presence of missing data · SiM · 2021-04-11 · 在第 22 页
- A comparison of statistical methods for allocating disease costs in the presence of interactions · SiM · 2021-04-11 · 在第 22 页
- Trajectory clustering using mixed classification models · SiM · 2021-04-07 · 在第 22 页
- Slamming the sham: A Bayesian model for adaptive adjustment with noisy control data · SiM · 2021-04-05 · 在第 22 页
- Multiparameter one‐sided tests for nonlinear mixed effects models with censored responses · SiM · 2021-04-05 · 在第 22 页
- Inferring latent heterogeneity using many feature variables supervised by survival outcome · SiM · 2021-04-05 · 在第 22 页
- Combined assessment of early and late‐phase outcomes in orphan drug development · SiM · 2021-04-04 · 在第 22 页
- Investigation of patient‐sharing networks using a Bayesian network model selection approach for congruence class models · SiM · 2021-04-02 · 在第 22 页
- A simple yet powerful test for assessing goodness‐of‐fit of high‐dimensional linear models · SiM · 2021-03-31 · 在第 23 页
- Spatial skew‐normal/independent models for nonrandomly missing clustered data · SiM · 2021-03-29 · 在第 23 页
- Semiparametric regression analysis of case‐cohort studies with multiple interval‐censored disease outcomes · SiM · 2021-03-29 · 在第 23 页
- Optimizing subgroup selection in two‐stage adaptive enrichment and umbrella designs · SiM · 2021-03-29 · 在第 23 页
- Fusion designs and estimators for treatment effects · SiM · 2021-03-29 · 在第 23 页
- Pathway testing for longitudinal metabolomics · SiM · 2021-03-26 · 在第 23 页
- Individual participant data meta‐analysis for external validation, recalibration, and updating of a flexible parametric prognostic model · SiM · 2021-03-26 · 在第 23 页
- Hierarchical Bayesian clustering design of multiple biomarker subgroups (HCOMBS) · SiM · 2021-03-26 · 在第 23 页
- Meta‐analysis methods for multiple related markers: Applications to microbiome studies with the results on multiple α‐diversity indices · SiM · 2021-03-25 · 在第 23 页
- Informative array testing with multiplex assays · SiM · 2021-03-24 · 在第 24 页
- A binary hidden Markov model on spatial network for amyotrophic lateral sclerosis disease spreading pattern analysis · SiM · 2021-03-24 · 在第 24 页
- Robust estimation of heterogeneous treatment effects using electronic health record data · SiM · 2021-03-19 · 在第 24 页
- Optimal planning of adaptive two‐stage designs · SiM · 2021-03-18 · 在第 24 页
- Sample size re‐estimation for covariate‐adaptive randomized clinical trials · SiM · 2021-03-17 · 在第 24 页
- Bayesian design and analysis of external pilot trials for complex interventions · SiM · 2021-03-17 · 在第 24 页
- On the design and the analysis of stratified biomarker trials in the presence of measurement error · SiM · 2021-03-16 · 在第 24 页
- A Bayesian approach for estimating age‐adjusted rates for low‐prevalence diseases over space and time · SiM · 2021-03-16 · 在第 24 页
- Estimation of treatment effect in 2‐in‐1 adaptive design and some of its extensions · SiM · 2021-03-15 · 在第 24 页
- Bayesian survival analysis with BUGS · SiM · 2021-03-13 · 在第 24 页
- Reduced rank multinomial logistic regression in Markov chains with application to cognitive data · SiM · 2021-03-10 · 在第 24 页
- Optimal and ethical designs for hypothesis testing in multi‐arm exponential trials · SiM · 2021-03-09 · 在第 24 页
- Nonparametric machine learning for precision medicine with longitudinal clinical trials and Bayesian additive regression trees with mixed models · SiM · 2021-03-09 · 在第 24 页
- Latent class mediator for multiple indicators of mediation · SiM · 2021-03-09 · 在第 24 页
- Clinical prediction models to predict the risk of multiple binary outcomes: Methodological issues · SiM · 2021-03-09 · 在第 24 页
- Censored functional data for incomplete follow‐up studies · SiM · 2021-03-09 · 在第 24 页
- Accounting for selection bias due to death in estimating the effect of wealth shock on cognition for the Health and Retirement Study · SiM · 2021-03-05 · 在第 25 页
- More robust estimation of average treatment effects using kernel optimal matching in an observational study of spine surgical interventions · SiM · 2021-03-04 · 在第 25 页
- Inverse probability weighted estimation for recurrent events data with missing category · SiM · 2021-03-04 · 在第 25 页
- Corrected score methods for estimating Bayesian networks with error‐prone nodes · SiM · 2021-03-04 · 在第 25 页
- A novel test by combining the maximum and minimum values among a large number of dependent Z‐scores with application to genome wide association study · SiM · 2021-03-04 · 在第 25 页
- A top scoring pairs classifier for recent HIV infections · SiM · 2021-03-03 · 在第 25 页
- uTPI: A utility‐based toxicity probability interval design for phase I/II dose‐finding trials · SiM · 2021-03-02 · 在第 25 页
- cLRT‐Mod: An efficient methodology for pharmacometric model‐based analysis of longitudinal phase II dose finding studies under model uncertainty · SiM · 2021-03-02 · 在第 25 页
- Exact confidence limits after a group sequential single arm binary trial · SiM · 2021-03-02 · 在第 25 页
- Comparative poisson clinical trials of multiple experimental treatments vs a single control using the negative multinomial distribution · SiM · 2021-03-02 · 在第 25 页
- Confidence intervals for difference in proportions for matched pairs compatible with exact McNemar's or sign tests · SiM · 2021-02-28 · 在第 25 页
- Selecting the model for multiple imputation of missing data: Just use an IC! · SiM · 2021-02-24 · 在第 25 页
- On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design · SiM · 2021-02-24 · 在第 25 页
- Propensity score trimming mitigates bias due to covariate measurement error in inverse probability of treatment weighted analyses: A plasmode simulation · SiM · 2021-02-23 · 在第 25 页
- Incorporating the dilution effect in group testing regression · SiM · 2021-02-17 · 在第 25 页
- Qualifying drug dosing regimens in pediatrics using Gaussian processes · SiM · 2021-02-15 · 在第 26 页
- Proportional likelihood ratio mixed model for discrete longitudinal data · SiM · 2021-02-15 · 在第 26 页
- Marginal analysis of current status data with informative cluster size using a class of semiparametric transformation cure models · SiM · 2021-02-15 · 在第 26 页
- Learning latent heterogeneity for type 2 diabetes patients using longitudinal health markers in electronic health records · SiM · 2021-02-15 · 在第 26 页
- Generalized linear mixed hiddensemi‐Markovmodels in longitudinal settings: A Bayesian approach · SiM · 2021-02-15 · 在第 26 页
- Consistency of the CRM when the dose‐toxicity curve is not monotone and its application to the POCRM · SiM · 2021-02-15 · 在第 26 页
- Space‐time modeling of child mortality at the Admin‐2 level in a low and middle income countries context · SiM · 2021-02-14 · 在第 26 页
- Predicting study duration in clinical trials with a time‐to‐event endpoint · SiM · 2021-02-12 · 在第 26 页
- Generalized confidence interval for an agreement between raters · SiM · 2021-02-12 · 在第 26 页
- Estimation and modeling of the restricted mean time lost in the presence of competing risks · SiM · 2021-02-10 · 在第 26 页
- A novel estimand to adjust for rescue treatment in randomized clinical trials · SiM · 2021-02-10 · 在第 26 页
- Semiparametric linear transformation models for indirectly observed outcomes · SiM · 2021-02-09 · 在第 26 页
- Randomization‐based inference in the presence of selection bias · SiM · 2021-02-09 · 在第 26 页
- Change‐point joint model for identification of plateau of activity in early phase trials · SiM · 2021-02-09 · 在第 26 页
- Integrative sparse partial least squares · SiM · 2021-02-08 · 在第 26 页
- A multistate model incorporating estimation of excess hazards and multiple time scales · SiM · 2021-02-08 · 在第 26 页
- Power and sample size for multistate model analysis of longitudinal discrete outcomes in disease prevention trials · SiM · 2021-02-07 · 在第 26 页
- Hybrid design evaluating new biomarkers when there is an existing screening test · SiM · 2021-02-04 · 在第 27 页
- District‐level estimation of vaccination coverage: Discrete vs continuous spatial models · SiM · 2021-02-04 · 在第 27 页
- Parametric and nonparametric improvements in Bland and Altman's assessment of agreement method · SiM · 2021-02-03 · 在第 27 页
- The length of the receiver operating characteristic curve and the two cutoff Youden index within a robust framework for discovery, evaluation, and cutoff estimation in biomarker studies involving improper receiver operating characteristic curves · SiM · 2021-02-02 · 在第 27 页
- The first‐order Markov conditional linear expectation approach for analysis of longitudinal data · SiM · 2021-02-02 · 在第 27 页
- Human disease clinical treatment network for the elderly: The analysis of medicare inpatient length of stay data · SiM · 2021-02-02 · 在第 27 页
- Displaying survival of patient groups defined by covariate paths: Extensions of the Kaplan‐Meier estimator · SiM · 2021-02-02 · 在第 27 页
- Point process models for sweat gland activation observed with noise · SiM · 2021-01-31 · 在第 28 页
- Capturing heterogeneity in repeated measures data by fusion penalty · SiM · 2021-01-31 · 在第 28 页
- Link predictions for incomplete network data with outcome misclassification · SiM · 2021-01-22 · 在第 28 页
- Dynamic prediction of disease processes based on recurrent history and functional principal component analysis of longitudinal biomarkers: Application for ovarian epithelial cancer · SiM · 2021-01-22 · 在第 28 页
- Spatial modeling of individual‐level infectious disease transmission: Tuberculosis data in Manitoba, Canada · SiM · 2021-01-20 · 在第 28 页
- Conditional adaptive Bayesian spectral analysis of replicated multivariate time series · SiM · 2021-01-20 · 在第 28 页
- Multiple imputation strategies for a bounded outcome variable in a competing risks analysis · SiM · 2021-01-19 · 在第 28 页
- A powerful test for the maximum treatment effect in thorough QT/QTc studies · SiM · 2021-01-19 · 在第 29 页
- A comparison of parametric propensityscore‐basedmethods for causal inference with multiple treatments and a binary outcome · SiM · 2021-01-18 · 在第 29 页
- A Bayesian‐bandit adaptive design for N‐of‐1 clinical trials · SiM · 2021-01-18 · 在第 29 页
- Two‐wave two‐phase outcome‐dependent sampling designs, with applications to longitudinal binary data · SiM · 2021-01-13 · 在第 29 页
- Scale mixture of skew‐normal linear mixed models with within‐subject serial dependence · SiM · 2021-01-12 · 在第 29 页
- Information content of stepped wedge designs with unequal cluster‐period sizes in linear mixed models: Informing incomplete designs · SiM · 2021-01-12 · 在第 29 页
- Detecting rare haplotype association with two correlated phenotypes of binary and continuous types · SiM · 2021-01-12 · 在第 29 页
- The optimal design of clinical trials with potential biomarker effects: A novel computational approach · SiM · 2021-01-11 · 在第 29 页
- Flexible multivariate joint model of longitudinal intensity and binary process for medical monitoring of frequently collected data · SiM · 2021-01-10 · 在第 29 页
- An alternative formulation of Coxian phase‐type distributions with covariates: Application to emergency department length of stay · SiM · 2021-01-10 · 在第 29 页
- Estimating the marginal hazard ratio by simultaneously using a set of propensity score models: A multiply robust approach · SiM · 2021-01-06 · 在第 29 页
- Cause‐specific quantile regression on inactivity time · SiM · 2021-01-06 · 在第 29 页
- A depth‐based global envelope test for comparing two groups of functions with applications to biomedical data · SiM · 2021-01-06 · 在第 29 页
- Extending the Mann‐Whitney‐Wilcoxon rank sum test to survey data for comparing mean ranks · SiM · 2021-01-04 · 在第 29 页